The latest research from Fore Pharma, ‘US Antipsoriasis Market Highlights – 2015’, provides the US Antipsoriasis market valuation, competitive landscape, and Antipsoriasis products sales in the US. The research includes US Antipsoriasis market size estimates for 2014, Antipsoriasis products market share, and Antipsoriasis products sales estimates. This research helps executives track competitor product sales and market share in the US Antipsoriasis market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US Antipsoriasis market.
Scope of the Research:
Antipsoriasis as defined in EphMRA Anatomical Therapeutic Chemical classification code D5A & D5B
Marketed Products: Identify Antipsoriasis products marketed including brand name, molecule name, and company
Sales Estimates: Find out estimates for the US Antipsoriasis market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate sales valuation of products and the market
Competitive Landscape: You will know the market share of leading Antipsoriasis products in 2014 and how they have changed from 2011
Pipeline: Find out key Antipsoriasis products in clinical trial phase 3 and phase 2. Coverage includes molecule, mechanism of action, and the company developing the product